Carvedilol Phosphate
12 NDCs across 3 manufacturers|12 Generic,0 Brand
Carvedilol Phosphate is used to treat angina pectoris, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 20, 2006, and the first generic was approved Oct 25, 2017. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $41 million on Carvedilol Phosphate across 90,000 claims for 22,000 beneficiaries.
Carvedilol Phosphate is available as 12 NDCs from 3 manufacturers (12 generic, 0 brand), with NADAC prices from $5.79 to $6.74 per EA — a 16% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
12
12G / 0B
Manufacturers
3
competing in market
Price Spread
$5.79 – $6.74
per EA
7d Activity
avg +1.3% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals of New York LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
alpha-Adrenergic Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing CARVEDILOL PHOSPHATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CARVEDILOL ER 20 MG CAPSULE | $6.7366 per EA | +2.64% |
CARVEDILOL ER 20 MG CAPSULE | $6.7366 per EA | +2.64% |
CARVEDILOL ER 20 MG CAPSULE | $6.7366 per EA | +2.64% |
CARVEDILOL ER 10 MG CAPSULE | $6.5204 per EA | +2.10% |
CARVEDILOL ER 10 MG CAPSULE | $6.5204 per EA | +2.10% |
CARVEDILOL ER 10 MG CAPSULE | $6.5204 per EA | +2.10% |
CARVEDILOL ER 40 MG CAPSULE | $6.3787 per EA | -1.02% |
CARVEDILOL ER 40 MG CAPSULE | $6.3787 per EA | -1.02% |
CARVEDILOL ER 40 MG CAPSULE | $6.3787 per EA | -1.02% |
CARVEDILOL ER 80 MG CAPSULE | $5.7916 per EA | +1.49% |
CARVEDILOL ER 80 MG CAPSULE | $5.7916 per EA | +1.49% |
CARVEDILOL ER 80 MG CAPSULE | $5.7916 per EA | +1.49% |
Frequently Asked Questions
What is Carvedilol Phosphate used to treat?
Carvedilol Phosphate is used to treat angina pectoris, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
When did Carvedilol Phosphate become available as a generic?
FDA approved the first generic Carvedilol Phosphate (ANDA) on Oct 25, 2017. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Carvedilol Phosphate?
In 2024, Medicare Part D spent $41 million on Carvedilol Phosphate across 90,000 claims for 22,000 beneficiaries.
How many Carvedilol Phosphate products are on the market?
The Carvedilol Phosphate drug market contains 12 NDCs from 3 manufacturers — 12 generic and 0 brand products.
What is the price range for Carvedilol Phosphate?
NADAC reference prices for Carvedilol Phosphate range from $5.7916 to $6.7366 per EA — a 16% difference between cheapest and most expensive.
Which manufacturers make Carvedilol Phosphate?
3 manufacturers list Carvedilol Phosphate in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals of New York LLC (4), Sun Pharmaceutical Industries Inc. (4), NorthStar Rx LLC (4).
How has the price of Carvedilol Phosphate changed recently?
Over the past 7 days, 18 Carvedilol Phosphate NDCs rose and 6 fell, with a market-wide average change of +1.3%.